Your browser doesn't support javascript.
loading
Norcantharidin ameliorates estrogen deficient-mediated bone loss by attenuating the activation of extracellular signal-regulated kinase/ROS/NLRP3 inflammasome signaling.
Yang, Guang; Xu, Huikang; Yao, Minjun; Yan, Shigui; Wu, Mengrui; Zhou, Chenhe.
Affiliation
  • Yang G; Department of Orthopedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou City, Zhejiang, China.
  • Xu H; Orthopedics Research Institute of Zhejiang University, Hangzhou City, Zhejiang, China.
  • Yao M; Key Laboratory of Motor System Disease Research and Precision Therapy of Zhejiang Province, Hangzhou City, Zhejiang, China.
  • Yan S; Clinical Research Center of Motor System Disease of Zhejiang Province, Hangzhou City, China.
  • Wu M; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, C
  • Zhou C; Department of Orthopedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou City, Zhejiang, China.
Front Pharmacol ; 13: 1019478, 2022.
Article in En | MEDLINE | ID: mdl-36408264
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Pharmacol Year: 2022 Document type: Article Affiliation country: China Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Pharmacol Year: 2022 Document type: Article Affiliation country: China Country of publication: Switzerland